Author:
Shimoda Kakeru,Nishimura Akiyuki,Sunggip Caroline,Ito Tomoya,Nishiyama Kazuhiro,Kato Yuri,Tanaka Tomohiro,Tozaki-Saitoh Hidetoshi,Tsuda Makoto,Nishida Motohiro
Abstract
AbstractCardiac tissue remodeling caused by hemodynamic overload is a major clinical outcome of heart failure. Uridine-responsive purinergic P2Y6 receptor (P2Y6R) contributes to the progression of cardiovascular remodeling in rodents, but it is not known whether inhibition of P2Y6R prevents or promotes heart failure. We demonstrate that inhibition of P2Y6R promotes pressure overload-induced sudden death and heart failure in mice. In neonatal cardiomyocytes, knockdown of P2Y6R significantly attenuated hypertrophic growth and cell death caused by hypotonic stimulation, indicating the involvement of P2Y6R in mechanical stress-induced myocardial dysfunction. Unexpectedly, compared with wild-type mice, deletion of P2Y6R promoted pressure overload-induced sudden death, as well as cardiac remodeling and dysfunction. Mice with cardiomyocyte-specific overexpression of P2Y6R also exhibited cardiac dysfunction and severe fibrosis. In contrast, P2Y6R deletion had little impact on oxidative stress-mediated cardiac dysfunction induced by doxorubicin treatment. These findings provide overwhelming evidence that systemic inhibition of P2Y6R exacerbates pressure overload-induced heart failure in mice, although P2Y6R in cardiomyocytes contributes to the progression of cardiac fibrosis.
Funder
Japan Society for the Promotion of Science
Joint Research of ExCELLS
Takeda Science Foundation
Kato Memorial Bioscience Foundation
Joint Research of NIPS
Japan Agency for Medical Research and Development
Naito Foundation
Suzuken Memorial Foundation
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. Cohn, J. N., Ferrari, R. & Sharpe, N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an International Forum on Cardiac Remodeling. J. Am. Coll. Cardiol. 35, 569–582 (2000).
2. Azevedo, P. S. et al. Cardiac remodeling: concepts, clinical impact, pathophysiological mechanisms and pharmacologic treatment. Arq. Bras. Cardiol. 106, 62–69 (2016).
3. Nishimura, A. et al. Depolysulfidation of Drp1 induced by low-dose methylmercury exposure increases cardiac vulnerability to hemodynamic overload. Sci. Signal. https://doi.org/10.1126/scisignal.aaw1920 (2019).
4. Sunggip, C. et al. Purinergic P2Y6 receptors: a new therapeutic target of age-dependent hypertension. Pharmacol. Res. 120, 51–59 (2017).
5. Burnstock, G. Purine and pyrimidine receptors. Cell. Mol. Life Sci. https://doi.org/10.1007/s00018-007-6497-0 (2007).
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献